On February 20, 2020, the 2020 1st K-BIC STAR DAY was held at the Biohealth Innovation Start-up Center in Jung-gu, Seoul, to provide startups with investment opportunities and networking opportunities.
47 companies participated in the K-BIC STAR DAY IR program from 2018 to the end of last year, and the participating companies attracted investment of 4 billion KRW in 2018 and 33.3 billion KRW in 2019. This year's expected effects will be even higher since the event will be held by major themes to reflect the latest issues and trends in the bio industry.
The AI healthcare industry, the theme of the first K-BIC STAR DAY in 2020, is being promoted by many global companies such as Google, IBM, and Tencent as the core industries of the future. It announced its intention to strategically foster the AI industry by proclaiming 'National Strategy'. Repure Life Science has presented Repureme(a personalized healthcare service platform) AI drug development, applications, and exercise prescription programs through personalized health care platform, patient data analysis and disease and research.
Photo: Kim Yong-Sang, CEO of Repure Life Science.
Um Bo-young, head of the Industry Promotion Division, said, “We are leading the funding support, the biggest difficulty of start-up companies since the opening of the Biohealth Innovation Start-up Center, and we see visible results through K-BIC STAR DAY. We hope to increase the concentration of VCs and to link investment directly through themes.
The Biohealth Innovation Start-up Center began with one AI healthcare held on February 20, followed by two digital healthcare, three doctor startups, four new drug developments, five free topics, and six events. The company plans to continue holding IR events by theme, such as the Forum.